Anchor Therapeutics Company
Anchor Therapeutics develops pharmaceutical candidates to address cancer, inflammation, metabolism, heart disease, and pain.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2006
Employees Number:
11-50
Funding Status:
Early Stage Venture
Total Funding:
29000000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Register and Claim Ownership